• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病细胞系:慢性中性粒细胞白血病研究的体外模型。

Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.

机构信息

Faculty of Life Sciences, Technical University of Braunschweig, 38106 Braunschweig, Germany.

Department of Human and Animal Cell Lines, Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures, 38124 Braunschweig, Germany.

出版信息

Curr Oncol. 2021 May 10;28(3):1790-1794. doi: 10.3390/curroncol28030166.

DOI:10.3390/curroncol28030166
PMID:34068566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8161829/
Abstract

Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm that is genetically characterized by the absence of both the Philadelphia chromosome and BCR-ABL1 fusion gene and the high prevalence of mutations in the colony-stimulating factor 3 receptor (CSF3R). Additional disease-modifying mutations have been recognized in CNL samples, portraying a distinct mutational landscape. Despite the growing knowledge base on genomic aberrations, further progress could be gained from the availability of representative models of CNL. To address this gap, we screened a large panel of available leukemia cell lines, followed by a detailed mutational investigation with focus on the CNL-associated candidate driver genes. The sister cell lines CNLBC-1 and MOLM-20 were derived from a patient with CNL and carry CNL-typical molecular hallmarks, namely mutations in several genes, such as CSF3R, ASXL1, EZH2, NRAS, and SETBP1. The use of these validated and comprehensively characterized models will benefit the understanding of the pathobiology of CNL and help inform therapeutic strategies.

摘要

慢性中性粒细胞白血病(CNL)是一种罕见的骨髓增殖性肿瘤,其遗传特征为既不存在费城染色体和 BCR-ABL1 融合基因,又普遍存在集落刺激因子 3 受体(CSF3R)突变。在 CNL 样本中还发现了其他疾病修饰突变,描绘了一个独特的突变景观。尽管对基因组异常的了解不断增加,但如果有代表性的 CNL 模型,可能会取得进一步的进展。为了解决这一差距,我们筛选了大量现有的白血病细胞系,然后对 CNL 相关候选驱动基因进行了详细的突变研究。姐妹细胞系 CNLBC-1 和 MOLM-20 源自一名患有 CNL 的患者,携带 CNL 典型的分子特征,即多个基因(如 CSF3R、ASXL1、EZH2、NRAS 和 SETBP1)发生突变。使用这些经过验证和全面表征的模型将有助于理解 CNL 的病理生物学,并有助于为治疗策略提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d5/8161829/edd06c23e4a6/curroncol-28-00166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d5/8161829/edd06c23e4a6/curroncol-28-00166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d5/8161829/edd06c23e4a6/curroncol-28-00166-g001.jpg

相似文献

1
Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.白血病细胞系:慢性中性粒细胞白血病研究的体外模型。
Curr Oncol. 2021 May 10;28(3):1790-1794. doi: 10.3390/curroncol28030166.
2
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.慢性中性粒细胞白血病和不典型慢性髓性白血病:2024 年诊断、遗传学、风险分层和治疗更新。
Am J Hematol. 2024 Jul;99(7):1360-1387. doi: 10.1002/ajh.27321. Epub 2024 Apr 21.
3
CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.CSF3R T618I、SETBP1 G870S、SRSF2 P95H和ASXL1 Q780*四重突变共同促成慢性嗜中性粒细胞白血病中的成髓细胞转化。
Ann Hematol. 2021 Jun;100(6):1459-1461. doi: 10.1007/s00277-021-04491-2. Epub 2021 Apr 6.
4
Genomics of chronic neutrophilic leukemia.慢性嗜中性粒细胞白血病的基因组学
Blood. 2017 Feb 9;129(6):715-722. doi: 10.1182/blood-2016-10-695981. Epub 2016 Dec 27.
5
Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.伴有 CSF3R 突变的慢性中性粒细胞白血病合并骨髓纤维化、发育异常和 X 染色体异常:病例报告及文献复习。
BMC Cancer. 2018 Mar 27;18(1):343. doi: 10.1186/s12885-018-4236-6.
6
Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.慢性嗜中性粒细胞白血病患者基因突变特征分析
Hematology. 2019 Dec;24(1):538-543. doi: 10.1080/16078454.2019.1642554.
7
Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.CSF3R、SRSF2和SETBP1突变在慢性嗜中性粒细胞白血病和慢性粒单核细胞白血病中的临床意义
Oncotarget. 2017 Mar 28;8(13):20834-20841. doi: 10.18632/oncotarget.15355.
8
CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.CSF3R 突变型髓系肿瘤:超越慢性中性粒细胞白血病。
Hum Pathol. 2024 Jul;149:66-74. doi: 10.1016/j.humpath.2024.06.008. Epub 2024 Jun 13.
9
Research progress of additional pathogenic mutations in chronic neutrophilic leukemia.慢性中性粒细胞白血病中附加致病性突变的研究进展。
Ann Hematol. 2024 Aug;103(8):2591-2600. doi: 10.1007/s00277-023-05550-6. Epub 2023 Nov 22.
10
CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.慢性嗜中性粒细胞白血病中的CSF3R、SETBP1和CALR突变
J Hematol Oncol. 2014 Oct 15;7:77. doi: 10.1186/s13045-014-0077-1.

本文引用的文献

1
The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research.LL-100 细胞系面板:用于分子白血病-淋巴瘤研究的工具。
Int J Mol Sci. 2020 Aug 13;21(16):5800. doi: 10.3390/ijms21165800.
2
There is a Scientific Need for the Right Leukemia-Lymphoma Cell Lines.对合适的白血病-淋巴瘤细胞系存在科学需求。
Hemasphere. 2019 Oct 31;3(6):e315. doi: 10.1097/HS9.0000000000000315. eCollection 2019 Dec.
3
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.芦可替尼治疗慢性中性粒细胞白血病和不典型慢性髓性白血病患者的疗效。
J Clin Oncol. 2020 Apr 1;38(10):1006-1018. doi: 10.1200/JCO.19.00895. Epub 2019 Dec 27.
4
Cancer Cell Lines Are Useful Model Systems for Medical Research.癌细胞系是医学研究中有用的模型系统。
Cancers (Basel). 2019 Aug 1;11(8):1098. doi: 10.3390/cancers11081098.
5
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.中性粒细胞白血病的基因组全景分析——诊断不明。
Blood. 2019 Sep 12;134(11):867-879. doi: 10.1182/blood.2019000611. Epub 2019 Jul 31.
6
The LL-100 panel: 100 cell lines for blood cancer studies.LL-100 面板:用于血液癌症研究的 100 种细胞系。
Sci Rep. 2019 Jun 3;9(1):8218. doi: 10.1038/s41598-019-44491-x.
7
Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.慢性中性粒细胞白血病:2018 年诊断、分子遗传学和治疗的更新。
Am J Hematol. 2018 Aug;93(4):578-587. doi: 10.1002/ajh.24983.
8
Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.靶向下一代测序在慢性中性粒细胞白血病患者的诊断和急变期鉴定出具有临床意义的突变。
Clin Transl Oncol. 2018 Mar;20(3):420-423. doi: 10.1007/s12094-017-1722-2. Epub 2017 Jul 31.
9
Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.CSF3R、SRSF2和SETBP1突变在慢性嗜中性粒细胞白血病和慢性粒单核细胞白血病中的临床意义
Oncotarget. 2017 Mar 28;8(13):20834-20841. doi: 10.18632/oncotarget.15355.
10
Genomics of chronic neutrophilic leukemia.慢性嗜中性粒细胞白血病的基因组学
Blood. 2017 Feb 9;129(6):715-722. doi: 10.1182/blood-2016-10-695981. Epub 2016 Dec 27.